Stay updated on Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T15:55:49.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added new oncology-related terms and upgraded revision to v3.1.0; removed the Liver Cancer topic and old v3.0.2 revision.
    Difference
    1%
    Check dated 2025-09-29T09:52:12.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2. Removed the Back to Top element.
    Difference
    0.2%
    Check dated 2025-09-14T23:55:38.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T20:39:01.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has added significant information regarding a facility name, location, and relevant publications related to liver cancer and pembrolizumab, while removing various location terms and resources previously listed.
    Difference
    8%
    Check dated 2025-08-31T13:00:22.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T05:24:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-TACE in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-TACE in Liver Cancer Clinical Trial page.